Reducing Socioeconomic Disparities in Health at Pediatric Visits (WECARE01)

May 14, 2021 updated by: Boston Medical Center
This research project is aimed to assess the effectiveness and impact of a pediatric-based intervention aimed at reducing low-income families' unmet material needs (food, housing, employment, childcare, household heat, education and learning the English language ) on child health.

Study Overview

Detailed Description

This project builds upon the PI's prior studies including a recently completed cluster randomized controlled trial (RCT) at community health centers in Boston, which demonstrated a positive impact on provider referrals, discussion, and family receipt of resources.

This study will specifically test the effectiveness of a further strengthened intervention "WE CARE 2.0" on provider referrals and family receipt of resources, along with its impact on child health, health care utilization, and developmental outcomes. Finally, we will gather information from stakeholders at the health centers in order to learn more about the facilitators and barriers to implementation of the model.

The study will take place at six community health centers in the Greater Boston area. The centers will be randomized to either an intervention or control site. Data will be collected on referrals, receipt of resources, and child outcomes from the child's electronic medical record (EMR) from birth to age 3. Focus groups will be used to gather implementation data from intervention health center personnel.

The WE CARE 2.0 intervention consists of: 1) WE CARE surveys which parents complete prior to their child's well-child visits; 2) information technology (IT) generated provider referrals which providers use to provide families with resource information sheets; 3) peer patient navigators who assist families in connecting to available resources and updating providers; and 4) training sessions for providers and office staff.

Families attending the control health centers will receive standard of care. Of note, since the health centers share a common EMR and for ethical reasons, control sites will have access to the IT generated referral mechanism.

Study Type

Interventional

Enrollment (Actual)

1205

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02118
        • South End Community Health Center
      • Boston, Massachusetts, United States, 02122
        • Dorchester House Multi-Service Center
      • Boston, Massachusetts, United States, 02124
        • Codman Square Health Center
      • Dorchester, Massachusetts, United States, 02125
        • Uphams Corner Health Center
      • Mattapan, Massachusetts, United States, 02126
        • Mattapan Community Health Center
      • Roslindale, Massachusetts, United States, 02131
        • Greater Roslindale Medical and Dental Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 day to 1 month (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Child is on Medicaid insurance
  • Is attending routine newborn visit

Exclusion Criteria:

  • Premature (less than or equal to 32 weeks GA)
  • Has a chronic disease
  • Has Neonatal Abstinence Syndrome
  • Has a foster parent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention-WE CARE
  1. The WE CARE survey is used to identify unmet material needs; it will be administered with patient's developmental screening forms at all health supervision visits from birth to two years of age.
  2. Providers will be trained to review the WE CARE survey at health supervision visits and generate our WE CARE community resource handouts (referrals) through the EMR.
  3. A peer patient navigator will offer personalized guidance to families with accessing community resources. The patient navigator will be available for at least a 1/2 day per week at each intervention health center to meet with families and offer guidance. Providers can communicate the patient navigator to refer families via the electronic medical record and families will also have the opportunity to contact the peer navigator at any time via the hotline number listed on the referral information sheets.
The WE CARE survey, consists of 14 questions used to identify seven unmet material needs (education, employment, food security, housing, childcare, household heat, language). The survey will be administered with patient's developmental screening forms at all health supervision visits from birth to two years of age. The office staff will instruct parents to give the WE CARE survey, along with the developmental screening tool, to their child's provider at the visit.
Providers will be trained to review the WE CARE survey at health supervision visits and generate referrals thru the EMR. Specifically, they will receive a one-hour teaching session one week prior to the study implementation. The goals for the session will include providing an overview of pediatric practice guidelines, introducing the WE CARE survey, reviewing the referral process, and discussing the role of peer patient navigators. Study staff will conduct periodic booster sessions; study staff will also train new providers should there be staff turnover
Other Names:
  • Resource Referral
The peer patient navigator will offer guidance to families with accessing community resources. They will be available at least .5 days per week at intervention health centers to meet with families and offer guidance as well as be available via a hotline number. The navigator will speak with families and offer guidance on community resources and offer assistance with completing applications. In addition, they will offer to schedule and, if desired, accompany parents to the agencies. Interpreter services will be utilized at the health centers in case the navigator does not speak the parent's language. The navigator will also place an update note in the EMR within 1-month post-visit and one week after any contact with families.
No Intervention: Control-Standard of Care
Participants in the delayed-intervention control group will receive standard pediatric care. However, since the health centers share a common EMR, and for ethical reasons, investigators will also embed the health IT referral mechanism into the EMR at the control sites. Control providers will be made aware of this prior to the start of the study. Although this may potentially reduce the effect size, the investigator's prior study found that the impact on referral rates of provider access to resource information was minimal. Families at control health centers will not receive the WE CARE surveys at health supervision visits and will not have access to the peer patient navigators

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health care utilization
Time Frame: Throughout child's enrollment in study (0 years through 3 years of age)
Investigators will measure whether child is up to date with well child visits between 0-3 years of age. Investigators will measure whether child is up to date on their immunizations between 0-3 years of age. Investigators will measure if and how many times child has been hospitalized or had a visit to the emergency department (ED) between 0-3 years of age.
Throughout child's enrollment in study (0 years through 3 years of age)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Child maltreatment
Time Frame: Throughout child's enrollment in study (0 years through 3 years of age)
Investigators will measure in the child's EMR whether or not there are any reports of child maltreatment and/or involvement with the Department of Child and Families, at any point, from age 0-3 years of age.
Throughout child's enrollment in study (0 years through 3 years of age)
Developmental delay
Time Frame: Throughout child's enrollment in study (0 years through 3 years of age)
Investigators will measure whether a developmental delay has been added to the child's problem list in their EMR or if provider has noted a concern of a developmental delay in their routine well-child care notes, at any point, from age 0-3 years of age.
Throughout child's enrollment in study (0 years through 3 years of age)
Obesity
Time Frame: Measured at 2-year, 30-month, and 3-year well child care visits (as recommended by the American Academy of Pediatrics)
Investigators will record the child's reported BMI at their 2-year, 30-month, and 3-year well child care visits from the EMR
Measured at 2-year, 30-month, and 3-year well child care visits (as recommended by the American Academy of Pediatrics)
Asthma
Time Frame: Throughout child's enrollment in study (0 years through 3 years of age)
Investigators will record whether asthma or concerns about asthma have been added to child's problem list in the EMR or noted in the EMR by child's provider at any point, from age 0-3 years of age.
Throughout child's enrollment in study (0 years through 3 years of age)
Blood pressure
Time Frame: Measured at 3-year well child care visits
We will record the child's reported blood pressure number as measured at their 3-year well child care visit. We will gather this information from the EMR.
Measured at 3-year well child care visits
Provider referrals
Time Frame: Throughout child's enrollment in study (0 years through 3 years of age)
Investigators will measure if and how many times a provider made a referral/printed out a community resource handout for patients during their enrollment in the study at any point, from age 0-3 years of age.
Throughout child's enrollment in study (0 years through 3 years of age)
Family receipt of community based resource
Time Frame: Throughout child's enrollment in study (0 years through 3 years of age)
Investigators will determine whether families who were printed out community resource handouts had been able to receive services from a community based resource organization. This will be recorded in the EMR by the patient navigator at anytime from age 0-3 years of age.
Throughout child's enrollment in study (0 years through 3 years of age)
Focus group data gathered by audio recordings then transcribed and coded
Time Frame: During 1st month pilot phase and again after investigators have enrolled our the cohort, approximately 3 years after the first focus groups and the study initiation
Investigators will gain insight into the context and implementation of the augmented WE CARE model from providers and administrative staff at the intervention sites
During 1st month pilot phase and again after investigators have enrolled our the cohort, approximately 3 years after the first focus groups and the study initiation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Arvin Garg, MD MPH, Boston University Medical Campus

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2015

Primary Completion (Actual)

December 29, 2020

Study Completion (Actual)

December 29, 2020

Study Registration Dates

First Submitted

May 14, 2015

First Submitted That Met QC Criteria

May 19, 2015

First Posted (Estimate)

May 21, 2015

Study Record Updates

Last Update Posted (Actual)

May 18, 2021

Last Update Submitted That Met QC Criteria

May 14, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • H-33061
  • 1R01MD007793-01A1 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on WE CARE survey

3
Subscribe